The Advanced Practitioner Society for Hematology and Oncology (APSHO) has been formally acknowledged as a national stakeholder and was honored to contribute its perspective on the future of the cancer workforce to the President’s Cancer Panel.

Strengthening the hematology/oncology workforce remains essential to ensuring that every patient has access to timely, high‑quality cancer care. APSHO’s involvement reflects its ongoing commitment to supporting advanced practitioners and enhancing the delivery of oncology services nationwide.

In its 2026 report, the President’s Cancer Panel underscored the urgent need for greater collaboration, expanded educational pathways, and improved support systems across all cancer care teams. The report highlighted APSHO’s role in advancing postgraduate oncology education—an essential component in addressing current workforce gaps and preparing clinicians for the evolving needs of patients.

Learn more about the Panel’s focus on the cancer workforce and read the full report here:
🔗 https://prescancerpanel.cancer.gov/reports-meetings/cancer-workforce-2026

READ THE FULL PRESS RELEASE HERE

APSHO Calls for a Minimum of 8 Hours of Protected Administrative Time for Advanced Practitioners in Oncology 

The Advanced Practitioner Society for Hematology and Oncology (APSHO) has issued a powerful new position statement calling for a minimum of eight (8) hours per week of protected administrative time for full-time, clinical advanced practitioners (APs) in outpatient oncology and hematology settings.

• Recognize signs and symptoms
• Understand classification, staging, and prognosis
• Coordinate care across specialties
• Manage patients based on symptom burden and disease severity
• Provide strategies for improving quality of life

Explore 15 reference tables, visual guides, and curated provider and patient online resources for this complex disease.

Read more here.

Click the button below to get yours today! 

Explore Here

Funding and support provided by Johnson & Johnson and Legend Biotech.

Dive into the comprehensive “Dermatologic Considerations During Cancer Therapy” module, now available in a variety of engaging formats. Whether you prefer to watch a dynamic video presentation, flip through informative slides, or simply listen to the audio, we’ve got you covered.

Enhance Your Expertise Today!

Please join us in congratulating our newest Board member:

Haleigh E. Mistry, MS PA-C
MD Anderson Cancer Center, Houston, Texas

And join us in welcoming back our re-elected Board members:

Yi (Lisa) Hwa, APRN, DNP, CNP, FAPO
Mayo Clinic, Rochester, Minnesota

Kate Taucher, PharmD, MHA, BCOP, FASHP, FAPO
UCHealth, Denver, Colorado

Presented in collaboration with the Advanced Practitioner Society for Hematology and Oncology (APSHO) and with the Society for Immunotherapy of Cancer (SITC)

It covers:

• Pre-conference preparation
• Effective networking
• Engaging with sessions and exhibitors
• Post-conference follow-up

Check out this FAQ that covers some of the most common questions you may have.

To learn more read the full press release here: https://www.prweb.com/releases/2023/2/prweb19132714.htm

October 21, 2020 – Lawrenceville, NJ – The Advanced Practitioner Society for Hematology and Oncology (APSHO) presented the fifth annual Mary Pazdur Award for Excellence in Advanced Practice in Oncology to Carrie Tompkins Stricker, PhD, RN, ANP-BC, CRNP, an associate professor at Thomas Jefferson University College of Nursing. Created in honor of the late Mary Pazdur, RN, MSN, the award is presented to an advanced practitioner and member of APSHO who consistently demonstrates exemplary leadership and outstanding contributions to clinical practice, research, and education in the oncology/hematology field.

Dr. Stricker is also the executive director of Canopy Cancer Collective, a learning health network of 14 NCI-designated cancer centers, dedicated to improving care and patient-defined quality survival for pancreatic cancer. In addition to her other roles, she is the president and founder of Accelerate Outcomes, LLC, a consulting company that provides expertise in all areas of health care and health technology for health system and corporate clients who want to improve their capacity and funding support to drive high quality outcomes.

Known for her oncology supportive care expertise as an oncology nurse practitioner, Dr. Stricker is respected for her leadership in using digital health and care delivery innovation to transform cancer care. "Carrie Stricker embodies the focus of the Mary Pazdur Award for Excellence in Advanced Practice in Oncology in so many ways," said APSHO Board of Directors President Sandra Kurtin, PhD, ANP-C, AOCN^®, FAPO, from the Arizona Cancer Center at the University of Arizona. "Carrie’s unrelenting innovation, exemplary leadership, patient-outcome–focused research, interdisciplinary collaboration, mentorship, and dedication to advancing the AP role exemplifies excellence."

Former colleagues describe a supportive and driven partner when talking about Dr. Stricker. After joining the CT Challenge Survivorship Network's Medical Advisory Board, where she advised on state-wide development of cancer survivorship programs and services, "she enhanced both the visibility and impact of oncology nurses and advanced practitioners in our state…in both community-based and academic settings," said Andrew Salner, MD, FACR, of the Hartford Healthcare Cancer Institute at Hartford Hospital in Connecticut.

A charter member of APSHO, Dr. Stricker is the founding director of Thomas Jefferson University College of Nursing's graduate program in Transformative Systems Leadership and an entrepreneur, health services researcher, and clinician. In 2013, she co-founded Carevive Systems, Inc., whose EMR-integrated cancer care digital platform enables evidence-based cancer care management and patient engagement to improve clinical outcomes. As chief clinical officer, Dr. Stricker saw Carevive's oncology solutions widely adopted and integrated for clinical and research use, and then expanded to include computerized algorithms for symptom management decision support.

Despite her many pursuits outside of the clinic, "Carrie has unerringly demonstrated her deep commitment to patient care by retaining an active practice as an oncology nurse practitioner," said Deborah Mayer, PhD, RN, AOCN^®, FAAN, of UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina. In her recommendation letter, Dr. Mayer cited the 2010 memoir of U.S. Senator (PA) Arlen Specter, Never Give In: Battling Cancer in the Senate, wherein he mentioned Dr. Stricker's "keen awareness of the psychological dimension of the cancer experience."

The award ceremony took place during JADPRO Live, an annual educational event during which the APSHO annual meeting takes place. The conference welcomes more than 1,000 attendees annually, including oncology/hematology nurse practitioners, physician assistants, pharmacists, and other advanced degree nurses and health-care professionals. Past recipients of the award include Jody Pelusi, PhD, FNP, AOCNP^®, of HonorHealth Research Institute in Scottsdale, Arizona; Jeannine Brant, PhD, APRN, AOCN^®, FAAN, of City of Hope Comprehensive Cancer Center in Duarte, California; Christina Cone, DNP, APRN, ANP-BC, AOCNP^®, of Duke Cancer Institute, Durham, North Carolina; and Allyson Price, PA-C, Thought Leader Liaison for AbbVie.

To learn more about the Mary Pazdur Award, please visit marypazduraward.com.

About JADPRO Live
JADPRO Live is a medical conference inspired by the Journal of the Advanced Practitioner in Oncology. This year’s meeting took place from October 20 through October 23 in Aurora, Colorado.

About APSHO
The Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society of nearly 4,000 oncology advanced practitioners, including nurse practitioners, physician assistants, pharmacists, clinical nurse specialists, and other health-care professionals. The mission of APSHO is to promote oncology patient care that is high quality, cost effective, and delivered through collaborative practice models by optimizing the role of the advanced practitioner as an integral member of the care team.

DATE – Lawrenceville, NJ ­– The Advanced Practitioner Society for Hematology and Oncology (APSHO) welcomes advanced practitioners—nurse practitioners, physician assistants and pharmacists—from Levine Cancer Institute as Institutional Members.

APSHO, now 2,600 members strong, is the only society dedicated to an interdisciplinary team approach to cancer treatment. The society’s mission is to improve the quality of care for patients with cancer by supporting critical issues in educational, clinical, and professional development for advanced practitioners in hematology and oncology.

Levine Cancer Institute is the southeast region’s top-rated cancer program and the only program in the nation to be Planetree-certified for compassionate, patient-centered care. With a team of 200+ leading cancer doctors and more than 25 cancer care locations, Levine Cancer Institute provides access to top-ranked physician expertise, groundbreaking clinical trials, and the latest cancer treatments across the Carolinas.

“Institutional membership demonstrates the highest commitment of a health-care institution to both patients and the advanced practitioners who care for them,” commented Wendy Vogel, MSN, FNP, AOCNP®, APSHO’s Executive Director. “The interdisciplinary team approach to cancer care is the best hope for improved patient outcomes. We are delighted that Levine is working with APSHO to provide critical clinical information and professional education to their advanced practitioners.”

Camille Valente, DNP, FNP-BC, Director of Advanced Practice at the Levine Cancer Institute and Co-Director of Hematology/Oncology APP Fellowship, stated, “Levine Cancer Institute is dedicated to providing professional growth opportunities and educational resources to our advanced practice providers (APPs). We are excited to extend new learning material as well as enhance connections and collaborative efforts with similar APPs across the country through APSHO.”

Institutional membership with APSHO provides institutions significant discounts on membership and clinical education, a cost savings that is essential at a time when educational budgets are shrinking and the science of oncology is expanding. The society offers advanced practitioners a rich network of oncology professionals to collaborate with. APSHO’s mentoring program gives professionals the opportunity to share expertise and best practices with colleagues across the country. The official journal of APSHO, the Journal of the Advanced Practitioner in Oncology, is a peer-reviewed, indexed publication that provides information on clinically relevant, evidence-based practice.

Learn more about APSHO and institutional membership at APSHO.org.

About APSHO

The Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society for advanced practitioners: nurse practitioners, physician assistants, pharmacists, clinical nurse specialists, and other oncology health-care professionals. The mission of APSHO is to promote oncology patient care that is high quality, cost effective, and delivered through collaborative practice models by optimizing the role of the advanced practitioner as an integral member of the care team.

“Carolyn Grande and Andrew Guinigundo will be valuable additions to our Board of Directors,” said Executive Director Wendy H. Vogel, MSN, FNP, AOCNP®. “Both of these advanced practitioners are deeply involved in the work of APSHO and demonstrate a passion for oncology and hematology.”

Carolyn Grande, CRNP, AOCNP®, of Abramson Cancer Center at the Hospital of the University of Pennsylvania, is an oncology nurse practitioner with 38 years of nursing experience. Ms. Grande is a founding member of APSHO, has served as the Chair of the Education Committee, and is a member of the Awards and Recognition Committee. Ms. Grande has served as the Associate Editor for APSHO’s official journal, Journal of the Advanced Practitioner in Oncology (JADPRO), since its inception in 2010. She lectures nationally and internationally on an extensive list of topics. She has published several book chapters and multiple articles in peer-reviewed journals.

“I have had the privilege of witnessing this professional organization and its leadership bring together a society addressing unmet needs of hematology and oncology advanced practitioners,” Ms. Grande said. “I look forward to serving on the board and contributing to the mission of APSHO moving forward.”

Andrew Guinigundo, MSN, RN, CNP, ANP-BC, is Genetics Lead at OHC, a large practice in Cincinnati, Ohio. He has presented and co-authored abstracts and posters at ASCO, MASCC, ONS, and JADPRO Live, and received the Outstanding Poster of the Year at JADPRO Live 2018. He helped to establish the Genetic Risk Evaluation and Testing (GREAT) Program at OHC in 2017, which was awarded an ACCC/Pfizer grant aimed at increasing genetic testing in breast cancer patients. He serves as the Lead for OHC GREAT and continues work as a medical oncology advanced provider. Mr. Guinigundo currently serves as the Chair of the APSHO Professional Development & Leadership Committee.

About APSHO
The Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society for nurse practitioners, PAs, pharmacists, and advanced degree nurses. The mission of APSHO is to improve the quality of care for patients with cancer by supporting critical issues in educational, clinical, and professional development for advanced practitioners in hematology and oncology.

About Harborside
Harborside is the foremost medical communications company that oncology clinicians turn to for accurate content, news, and education. The company is based in Huntington, New York, and is the publisher of the Journal of the Advanced Practitioner in Oncology (JADPRO), The ASCO Post, and JNCCN—Journal of the National Comprehensive Cancer Network. Harborside designs educational resources for nurse practitioners, PAs, pharmacists, and other advanced practitioners by publishing JADPRO, organizing the JADPRO Live conference, and providing the management services for the Advanced Practitioner Society for Hematology and Oncology (APSHO).

Allyson Price, PA-C, Honored With The Mary Pazdur Award for Excellence in Advanced Practice in Oncology by APSHO

Allyson Price, PA-C, formerly of The University of Texas MD Anderson Cancer Center, was presented with the fourth annual award by the Advanced Practitioner Society for Hematology and Oncology (APSHO). The award recognizes an exceptional leader, mentor, and champion of advanced practice in oncology/hematology.

October 11, 2020 – Lawrenceville, NJ ­– The Advanced Practitioner Society for Hematology and Oncology (APSHO) presented the fourth annual Mary Pazdur Award for Excellence in Advanced Practice in Oncology to Allyson Price, PA-C, formerly of The University of Texas MD Anderson Cancer Center. Created in honor of the late Mary Pazdur, RN, MSN, the award is presented to an advanced practitioner and member of APSHO who consistently demonstrates exemplary leadership and outstanding contributions to clinical practice, research, and education in the oncology/hematology field.

Allyson Price, PA-C, is a physician assistant who worked in the Department of Leukemia at MD Anderson Cancer Center for 7 years. Ms. Price managed acute and chronic leukemia patients in the outpatient and inpatient clinics and served as a preceptor for PA students and PA/NP fellows.

“Ally has a unique ability to understand patient needs and visualize how we can improve their experiences,” said Madeleine Henriques, MPAS, PA-C, of MD Anderson Cancer Center. Along with a group of advanced practitioners, Ms. Price created the Leukemia Education APP Program (LEAP) in November 2018 to educate patients and caregivers about acute leukemias, potential side effects, clinic resources, and financial assistance.

Colleagues, physicians, former students, and patients and their caregivers describe Ms. Price as a constant source of joy, expertise, and compassion. Her dedication to pursue the latest therapies and comprehensive services to provide exceptional care for her patients stood out in many minds, inspiring everyone who worked with her.

“For us, good patient care meant it had to get personal…For two years, I watched Ally care for my husband’s whole being with a level of love and true professionalism. Really, she cared for both of us,” commented a caregiver.

Ms. Price is also driven in education and research, publishing clinical research projects, specifically on FLT3-mutated acute myeloid leukemia, and helping develop educational programs on hematologic malignancies for the Journal of the Advanced Practitioner in Oncology. She is also an active member of APSHO committees, including the Education Committee and Communications Committee.

Gautam Borthakur, MD, of MD Anderson Cancer Center, talked about her commitment to training and mentoring new advanced practitioners as a supervisor. “She plans their rotations to maximize their experience, spends a lot of time with them, and in return asks for the same level of commitment from her trainees.” 

The award ceremony was aired during JADPRO Live Virtual, an annual educational event during which the APSHO annual meeting takes place. It welcomes over 1,000 attendees annually, including oncology/hematology nurse practitioners, physician assistants, pharmacists, and other advanced degree practitioners. Past recipients of the award include Jody Pelusi, PhD, FNP, AOCNP®, of HonorHealth Research Institute in Scottsdale, Arizona, Jeannine Brant, PhD, APRN, AOCN®, FAAN, of Billings Clinic in Billings, Montana, and Christina Cone, DNP, APRN, ANP-BC, AOCNP®, of Duke Cancer Institute, Durham, North Carolina.

To learn more about the Mary Pazdur Award, please visit marypazduraward.com.

About JADPRO Live

JADPRO Live is a medical conference inspired by the Journal of the Advanced Practitioner in Oncology. This year’s meeting takes place virtually from October 7 through 17, 2021.

About APSHO

The Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society of over 2,400 advanced practitioners, including nurse practitioners, physician assistants, pharmacists, clinical nurse specialists, and other oncology health-care professionals. The mission of APSHO is to promote oncology patient care that is high quality, cost effective, and delivered through collaborative practice models by optimizing the role of the advanced practitioner as an integral member of the care team.

The Advanced Practitioner Society for Hematology and Oncology (APSHO) welcomes more than 900 advanced practitioners—nurse practitioners, physician assistants and pharmacists—from Memorial Sloan Kettering Cancer Center (MSK) as its first institutional members.

APSHO, now 2,400 members strong, is the only society dedicated to an interdisciplinary team approach to cancer treatment. The society’s mission is to improve the quality of care for patients with cancer by supporting critical issues in educational, clinical, and professional development for advanced practitioners in hematology and oncology.

As the world’s oldest and largest private cancer center, MSK has devoted more than 135 years to exceptional patient care, influential educational programs and innovative research to discover more effective strategies to prevent, control and, ultimately, cure cancer. MSK is home to more than 20,000 physicians, scientists, nurses and staff united by a relentless dedication to conquering cancer. Today, it is one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, with state-of-the-art science and technology supporting groundbreaking clinical studies, personalized treatment, and compassionate care for patients. MSK also trains the next generation of clinical and scientific leaders in oncology through continually evolving educational programs, here and around the world. Year after year, MSK is ranked among the top two cancer hospitals in the country, consistently recognized for their expertise in adult and pediatric oncology specialties.

“Institutional membership demonstrates the highest commitment to both patients and the advanced practitioners who care for them,” commented Wendy Vogel, MSN, FNP, AOCNP®, APSHO’s Executive Director. “The interdisciplinary team approach to cancer care is the best hope for improved patient outcomes. We are delighted that MSK is working with APSHO to provide critical clinical information and professional education to their advanced practitioners.”

“I am constantly exploring ways to ensure that our advanced practice providers have access to relevant, quality educational materials to promote their continual clinical and professional growth,” said Aaron M. Begue, MS, RN, CNP, Executive Director of Advanced Practice Providers at MSK. “We were fortunate to connect with APSHO to provide access for our clinicians. We also appreciate the inclusiveness of APSHO in welcoming nurse practitioners, physician assistants, and pharmacists. These three professions work together every day to care for patients, and it makes perfect sense that they should all have access to the same relevant and high-quality educational resources.”

Institutional membership with APSHO provides institutions significant discounts on membership and clinical education, a cost savings that is essential at a time when educational budgets are shrinking and the science of oncology is expanding. The society offers advanced practitioners a rich network of oncology professionals to collaborate with. APSHO’s mentoring program gives professionals the opportunity to share expertise and best practices with colleagues across the country. The official journal of APSHO, the Journal of the Advanced Practitioner in Oncology, is a peer-reviewed, indexed publication that provides information on clinically relevant, evidence-based practice.

https://www.cms.gov/newsroom/fact-sheets/final-policy-payment-and-quality-provisions-changes-medicare-physician-fee-schedule-calendar-year-1

Christina Cone, DNP, APRN, ANP-BC, AOCNP®, of Duke Cancer Institute, was presented with the third annual award by the Advanced Practitioner Society for Hematology and Oncology (APSHO). The award recognizes an exceptional leader, mentor, and champion of advanced practice in oncology/hematology.  

September 9, 2020 – Lawrenceville, New Jersey – The Advanced Practitioner Society for Hematology and Oncology (APSHO) was awarded the 2020 Power of A (Association) Silver Award from the American Society of Association Executives (ASAE) for its work organizing a national oncology leadership summit for nurse practitioners, physician assistants, and pharmacists. The Power of A Award celebrates the extraordinary programs and initiatives undertaken by associations worldwide to enrich lives, advance the professions they represent, kickstart innovation, and improve world conditions.

The Advanced Practitioner Society for Hematology and Oncology is a 1,400-member strong organization for advanced practitioners—nurse practitioners, physician assistants, pharmacists, and other oncology health-care professionals. The mission of APSHO is to promote oncology patient care that is high quality, cost effective, and delivered through collaborative practice models by optimizing the role of the advanced practitioner as an integral member of the care team.

“This award celebrates APSHO’s extraordinary work in uplifting advanced practice leaders in oncology,” said Executive Director of APSHO, Wendy H. Vogel, MSN, FNP, AOCNP®. “It also demonstrates the power of multidisciplinary, collaborative practice and the passion for oncology that advanced practitioners have.”

APSHO took Silver in the 2020 award category of The Power of Industry/Professional Advancement for the National Oncology Advanced Practitioner Leadership Summit, which took place at JADPRO Live 2019 and aimed to address critical oncology issues by bringing oncology advanced practice leaders together to collaborate on leadership challenges. This category recognizes associations that have addressed professional advancement by developing innovative educational and professional development opportunities.

“Congratulations to APSHO on being named among the very best organizations that go above and beyond to improve society and our quality of life in America,” said ASAE President and CEO Susan Robertson, CAE. “This has been a very trying year for associations, but even amid a months-long pandemic, associations are proving that positive change can happen.”

About APSHO

The Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society for advanced practitioners—nurse practitioners, physician assistants, pharmacists, clinical nurse specialists, and other oncology health-care professionals. The mission of APSHO is to promote oncology patient care that is high quality, cost effective, and delivered through collaborative practice models by optimizing the role of the advanced practitioner as an integral member of the care team.

About Harborside

Harborside is the foremost medical communications company that oncology clinicians turn to for accurate content, news, and education. The company is based in Huntington, New York, and is the publisher of the Journal of the Advanced Practitioner in Oncology (JADPRO) , The ASCO Post, JNCCN—Journal of the National Comprehensive Cancer Network , and JCO Oncology Practice. Harborside designs educational resources for nurse practitioners, PAs, pharmacists, and other advanced practitioners by publishing JADPRO, organizing the JADPRO Live conferences, and providing the management services for the Advanced Practitioner Society for Hematology and Oncology. Harborside also manages the advertising sales for ASCO’s suite of publications, including JCO Oncology Practice, JCO Global Oncology, JCO Clinical Cancer Informatics, and JCO Precision Oncology.

About JADPRO
The mission of the Journal of the Advanced Practitioner in Oncology (JADPRO) is to improve the quality of care for patients with cancer, support critical issues in advanced practice in oncology, and recognize the expanding contributions of advanced practitioners in oncology. JADPRO is published by Harborside and is the official journal of the Advanced Practitioner Society for Hematology and Oncology (APSHO).

About Harborside
Harborside is the foremost medical communications company that oncology clinicians turn to for accurate content, news, and education. The company is based in Huntington, New York, and is the publisher of the Journal of the Advanced Practitioner in Oncology (JADPRO), The ASCO Post, JNCCN—Journal of the National Comprehensive Cancer Network, and JCO Oncology Practice. Harborside designs educational resources for nurse practitioners, PAs, pharmacists, and other advanced practitioners by publishing JADPRO, organizing the JADPRO Live conference, and providing the management services for the Advanced Practitioner Society for Hematology and Oncology.